Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: A Feasible and Effective Option for Colorectal Cancer Patients After Emergency Surgery in the Presence of Peritoneal Carcinomatosis

Hyperthermic intraperitoneal chemotherapy during primary tumour resection limits extent of bowel resection compared to two-stage treatment

(2013) H.J. Braam et al.   EJSO

Clinicopathological analysis of colorectal cancer: a comparison between emergency and elective surgical cases

(2013) Sam Ghazi et al.   World Journal of Surgical Oncology

Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer

(2012) J. Segelman et al.   BRITISH JOURNAL OF SURGERY

Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy

(2012) Y.L.B. Klaver et al.   EJSO

Upfront Compared to Delayed Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Is Associated With Considerably Lower Perioperative Morbidity and Recurrence Rate

(2011) Terence C. Chua et al.   ANNALS OF SURGERY

Emergency First Presentation of Colorectal Cancer Predicts Significantly Poorer Outcomes

(2011) Gary Bass et al.   DISEASES OF THE COLON & RECTUM

Outcomes of elderly patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for colorectal cancer peritoneal carcinomatosis

(2011) Yvonne L.B. Klaver et al.   JOURNAL OF SURGICAL ONCOLOGY

Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: A population-based study

(2010) Valery E. Lemmens et al.   INTERNATIONAL JOURNAL OF CANCER

The Perioperative Period is an Underutilized Window of Therapeutic Opportunity in Patients With Colorectal Cancer

(2009) Gerben J. van der Bij et al.   ANNALS OF SURGERY

Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis

(2008) Ju-Li Koh et al.   ANNALS OF SURGICAL ONCOLOGY

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival

(2008) J. Hagendoorn et al.   EJSO

Complete Cytoreductive Surgery Plus Intraperitoneal Chemohyperthermia With Oxaliplatin for Peritoneal Carcinomatosis of Colorectal Origin

(2008) Dominique Elias et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor Pathology and Long-Term Survival in Emergency Colorectal Cancer

(2007) Siu Kin C. Wong et al.   DISEASES OF THE COLON & RECTUM